Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Return on Sales (2022 - 2025)

Historic Return on Sales for Dare Bioscience (DARE) over the last 4 years, with Q3 2025 value amounting to 1623.41%.

  • Dare Bioscience's Return on Sales fell 15111200.0% to 1623.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 305.39%, marking a year-over-year increase of 3178000.0%. This contributed to the annual value of 2396.92% for FY2024, which is 23859000.0% down from last year.
  • Latest data reveals that Dare Bioscience reported Return on Sales of 1623.41% as of Q3 2025, which was down 15111200.0% from 180.8% recorded in Q2 2025.
  • Dare Bioscience's Return on Sales' 5-year high stood at 180.8% during Q2 2025, with a 5-year trough of 1623.41% in Q3 2025.
  • For the 4-year period, Dare Bioscience's Return on Sales averaged around 204.33%, with its median value being 3.14% (2023).
  • Over the last 5 years, Dare Bioscience's Return on Sales had its largest YoY gain of 5087900bps in 2025, and its largest YoY loss of -15111200bps in 2025.
  • Quarter analysis of 4 years shows Dare Bioscience's Return on Sales stood at 2.3% in 2022, then dropped by -24bps to 2.86% in 2023, then skyrocketed by 3060bps to 84.66% in 2024, then plummeted by -2018bps to 1623.41% in 2025.
  • Its Return on Sales was 1623.41% in Q3 2025, compared to 180.8% in Q2 2025 and 179.28% in Q1 2025.